¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï¾Æ»êº´¿ø 7th AP VALVES 2018 : 2018-08-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï¾Æ»êº´¿ø  7th AP VALVES 2018 : 2018-08-10
±³À°ÀÏÀÚ : 2018-08-10
±³À°Àå¼Ò : ¼­¿ï ±×·£µå ¿öÄ¿Èú ÁöÇÏ 2Ãþ ºñ½ºÅ¸È¦  
±³À°ÁÖÁ¦ : 7th AP VALVES 2018      
ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø 
´ã´çÀÚ : ±èÇöÁ¤
¿¬¶ôó : 02-3010-7255  
À̸ÞÀÏ : bellakim@summitmd.com      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 9 ½Ã°£ 45ºÐ  
¼¼ºÎ¼ö°­·á 0¿ø      
ºñ°í       
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 07:30~07:40 Successful Mitral Valve-in-Valve Using TAVR THV in a Patient with Severe MR Due to Bioprosthetic Valve Failure  Hyungdon Kook(Korea University Anam Hospital, Korea (Republic of)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 07:40~07:50 Coronary Obstruction After TAVR  Vincent Luk(Queen Elizabeth Hospital, Hong Kong, China) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 07:50~08:00 Stuck Balloon of Edwards Sapien 3 Valve in Thoracic Aorta  Nishant Gangil(Barts Heart Center, United Kingdom) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 08:00~08:10 Cardiac Rupture After TAVR  Edgar Lik-Wui Tay(National University Heart Centre, Singapore) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 08:10~08:20 Embolization After TAVR  Mao-Shin Lin(National Taiwan University Hospital, Taiwan) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 08:20~08:30 Case  Owen Christopher Raffel(Prince Charles Hospital, Australia) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 08:30~09:55 Asan Medical Center, Seoul, Korea: Case #1, #2  Seung-Jung Park(Asan Medical Center, Korea (Republic of)) 
±âŸ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 09:55~10:00 Opening Remark  Seung-Jung Park(Asan Medical Center, Korea (Republic of)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 10:00~10:10 Conscious Sedation or General Anesthesia for TAVR: When Should We Consider General Anesthesia?  In-Cheol Choi(Asan Medical Center, Korea (Republic of)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 10:10~10:20 Mainstream of TAVR: Minimalist Approach  Duk-Woo Park(Asan Medical Center, Korea (Republic of)) 
Åä·Ð 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 10:20~10:30 Discussion Between Panels and Audiences  Tai-Leung Daniel Chan(Queen Mary¡¯s Hospital, Hong Kong(China)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 10:30~12:00 Asan Medical Center, Seoul, Korea: Case #3, #4  Myeong-Ki Hong(Severance Hospital, Korea(Republic of)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:00~12:10 CT Algorithm to Avoid Permanent Pacemaker and Para-Valvular Leakage  Do-Yoon Kang(Asan Medical Center, Korea (Republic of)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:10~12:20 Sapien 3 or Evolut R: Different Indications?  Alan C. Yeung(Stanford University School of Medicine, USA) 
Åä·Ð 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:20~12:30 Panel Discussion with Q & A  Seung-Ho Hur(Keimyung University Dongsan Medical Center, Korea(Republic of)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:30~12:40 Management of Asymptomatic Severe AS  Duk-Hyun Kang(Asan Medical Center, Korea (Republic of)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:40~12:50 Low Gradient AS: How to Identify and Manage?  Yong-Jin Kim(Seoul National University Hospital, Korea (Republic of)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 12:50~13:00 TAVR in Low Risk Patients  Alan C. Yeung(Stanford University School of Medicine, USA) 
Åä·Ð 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:00~13:10 Panel Discussion with Q & A  Jung-Min Ahn(Asan Medical Center, Korea (Republic of)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:10~13:20 TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations  Jung-Min Ahn(Asan Medical Center, Korea (Republic of)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:20~13:30 Optimal Antithrombotic Therapy and Ongoing Clinical Trials  Duk-Woo Park(Asan Medical Center, Korea (Republic of)) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:30~13:40 MV and TV Intervention: Current Status and Future Perspectives  Horst Sievert(CardioVascular Center Frankfurt CVC, Germany) 
Åä·Ð 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:40~13:50 Panel Discussion with Q & A  David J. Cohen(Saint Luke's Mid America Heart Institute, USA) 
È޽Ġ08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 13:50~14:00   () 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 14:00~15:30 Cheng Hsin General Hospital, Taiwan: Case #1, #2  Jeng Wei(Cheng Hsin General Hospital, Taiwan) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 15:30~15:40 Patient and Device Selection for ViV TAVR: The Good, the Bad, and the Ugly  Horst Sievert(CardioVascular Center Frankfurt CVC, Germany) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 15:40~15:50 ViV TAVR: The Role of Bioprosthetic Valve Fracture  David J. Cohen(Saint Luke's Mid America Heart Institute, USA) 
Åä·Ð 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 15:50~16:00 Panel Discussion with Q & A  Ying-Hwa Chen(Taipei Veterans General Hospital, Taiwan) 
±³À°½Ã°£ 08¿ù 10ÀÏ ºñ½ºÅ¸È¦ 16:00~17:30 The Catholic University of Korea, Seoul St. Mary''''s Hospital, Seoul, Korea: Case #1, #2  Ki-Bae Seung(The Catholic University of Korea, Seoul St. Mary¡¯s Hospital, Korea(Republic of)) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï¾Æ»êº´¿ø 7th AP VALVES 2018 : 2018-08-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »ï¼º¼­¿ïº´¿ø 2018 »ï¼º ¾È°ú ±Ý¿äÁý´ãȸ : 2018-08-10
´ÙÀ½±Û Çѱ¹¿ªÇÐȸ ÀÇÇк¸°ÇÇп¡¼­ÀÇ ¿ªÇÐÀû »ç°í¿Í Åë°èÀÇ ÀÀ¿ë 2 : 2018-08-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20912 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 130 2024-05-28
20911 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 89 2024-05-28
20910 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 130 2024-05-28
20909 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 82 2024-05-28
20908 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 152 2024-05-28
20907 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 92 2024-05-28
20906 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 71 2024-05-28
20905 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 58 2024-05-28
20904 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 76 2024-05-28
20903 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 138 2024-05-28
20902 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 68 2024-05-28
20901 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 76 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 143 2024-05-28
20899 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 50 2024-05-28
20898 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 135 2024-05-28
21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷